DONALD HARVEY: Open Payments
NPI 1770502114 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 17 payments from 11 companies in 2025. Trend: 2023 $237 · 2024 $396 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $93 |
| Corcept Therapeutics | 3 | $71 |
| ABIOMED | 2 | $68 |
| BETA BIONICS, INC. | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| Bavarian Nordic A/S | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: Cologuard Collection Kit, Korlym, iLet Bionic Pancreas, Vivotif, YUPELRI, TRELEGY ELLIPTA, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
